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A cDNA encoding the human guanylate binding protein-1 (hGBP-1) was expressed in HeLa cells using a constitutive
expression vector. Stably transfected clones expressing hGBP-1 exhibited resistance to the cytopathic effect mediated by
both vesicular stomatitis virus (VSV) and encephalomyocarditis virus (EMCV) and produced less viral progeny than control
cells following infection with these viruses. To study the role hGBP-1 plays in the IFN-mediated antiviral effect, cells were
stably transfected with a construct expressing antisense RNA for hGBP-1. VSV infection of IFN-a-treated antisense
RNA-expressing cells produced an amount of virus comparable to that produced in the parental cell line, while EMCV
infection of the IFN-a-treated transfected cells and VSV and EMCV infection of the IFN-g-treated transfected cells produced
far more virus than was produced in the parental cell line. These results demonstrate that GBP-1 mediates an antiviral effect
against VSV and EMCV and plays a role in the IFN-mediated antiviral response against these viruses. © 1999 Academic Press
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aINTRODUCTION
The interferons (IFNs) are a family of regulatory mol-
cules, which, after binding to cell surface receptors of
esponsive cells, are capable of mediating an antiviral
tate, an antiproliferative effect, and a variety of immune
esponses (Lengyel, 1982; Pestka et al., 1987; Johnson,
987; Staeheli, 1990; Sen and Lengyel, 1992). The estab-
ishment of the antiviral effect by the IFNs is dependent
n de novo RNA and protein synthesis (Friedman and
onnabend, 1965; Lockart, 1964; Taylor, 1964). Extensive
haracterization of IFN-treated cells has revealed the
FN-mediated induction of new RNAs and proteins. Elu-
idation of the role these proteins play in the IFN-medi-
ted antiviral effect has in part been accomplished by
pecifically modulating the expression of particular IFN-
nduced gene products and then characterizing the an-
iviral responses of these cells. Through such studies,
nvestigators have demonstrated that: (1) murine Mx1
onfers resistance to influenza virus (Staeheli et al.,
986), Thogoto virus (Haller et al., 1995), and Dhori virus
Thimme et al., 1995); (2) functional murine Mx2 confers
esistance to vesicular stomatitis virus (VSV) (Zurcher et
l., 1992); (3) human MxA protein confers resistance to
nfluenza virus and VSV (Pavlovic et al., 1990), measles
irus (Schnorr et al., 1993), and Thogoto virus (Frese et
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rederick, MD 21701.
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8l., 1995; Thimme et al., 1995); (4) human double-
tranded RNA-activated p68 kinase (PKR) confers resis-
ance to encephalomyocarditis virus (EMCV) (Meurs et
l., 1992); and (5) human 29-59-oligoadenylate synthetase
OAS) confers resistance to Mengo virus and EMCV
Chebath et al., 1987; Coccia et al., 1990). Recent studies
mploying homologous recombination have enabled the
eneration of mice devoid of a functional PKR. Antiviral
tudies performed in these animals reveal that PKR plays
critical role in the antiviral effect mediated against
MCV following injection with poly(IC) or IFN-g (Yang et
l., 1995). These findings are consistent with those ob-
erved in cells constitutively expressing PKR. The role
ther IFN-induced gene products play in IFN-mediated
ntiviral effects remains to be elucidated.
The IFN-induced guanylate binding proteins (GBPs)
epresent a family of proteins whose role in IFN-medi-
ted biological effects is not understood. There are re-
orts of at least two forms of the IFN-induced GBPs in
uman and murine cells (Cheng et al., 1991; Wynn et al.,
991). The IFN-induced GBPs exhibit significant amino
cid sequence homology among themselves, have an
ffinity for guanylate, and function as GTPases (Cheng et
l., 1983; Schwemmle and Staeheli, 1994; Neun et al.,
996). These proteins contain the first two motifs but lack
he third motif of the tripartite consensus sequence re-
orted by Dever and co-workers to be present in nine
TP-binding protein families (Dever et al., 1987; Dever
nd Merrick, 1989). To investigate the biological activity
f the IFN-induced GBPs, we have generated and char-
cterized cells constitutively expressing the human IFN-nduced GBP-1 (hGBP-1) and cells producing a reduced
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9ANTIVIRAL EFFECT OF THE IFN-INDUCED GBP-1mount of GBPs in response to IFN treatment as a result
f the expression of an antisense RNA to hGBP-1. The
iological responsiveness of these cells is presented
erein.
RESULTS
solation of a full-length cDNA for hGBP-1
A lgt10 cDNA library prepared using mRNA isolated
rom IFN-g-treated FS4 cells was screened with a partial
DNA fragment for hGBP-1 isolated by Margolis-Nunno
t al. (1990). A lgt10 clone containing a full-length cDNA
nsert of approximately 2 kb that has .99% nucleotide
equence homology with the reported sequence of
GBP-1 (Locus HUMGBP1) was isolated (Cheng et al.,
991).
eneration of cells overexpressing hGBP-1
The cDNA for hGBP-1 was incorporated into the pBact-
eo vector in which constitutive expression of the insert
s driven by the b-actin promoter (Reis et al., 1992) in an
rientation that resulted in the expression of hGBP-1
NA. Transfection of HeLa cells with this plasmid re-
ulted in the generation of clones resistant to G418. The
bility of these cells to constitutively synthesize hGBP-1
as determined by immunoprecipitation using monoclo-
al antibody developed against and capable of recogniz-
ng hGBP-1. As can be seen in Fig. 1, two clones, termed
7-6 and 67-7, that constitutively express hGBP-1 were
dentified.
eplication of virus in cells constitutively expressing
GBP-1
The ability of virus to replicate in cells constitutively
xpressing hGBP-1 was first studied by assessing the
ytopathic effect of VSV and EMCV on these cells. The
arental cell line and clones 67-6 and 67-7 were infected
ith either VSV or EMCV at a multiplicity of infection
m.o.i.) of 1 as described under Materials and Methods.
FIG. 1. Immunoprecipitation of hGBP-1 from cells stably transfected
ith the hGBP-1 producing pBactneo vector. The parental HeLa cell
ine and two G418-resistant clones termed 67-6 and 67-7 that were
tably transfected with the constitutive hGBP-1 producing pBactneo
ector were incubated in the presence of [35S]methionine for 18 h at
hich time the cells were lysed and immunoprecipitations employing a
onoclonal antibody to hGBP-1 were performed as described (Rubin et
l., 1988a).ighteen hours later the culture medium was removed cnd the cytopathic effect of virus infection was examined
y staining the wells with crystal violet. As can be seen
n Fig. 2, the hGBP-1 producing cells exhibited far less
SV- and EMCV-mediated cytopathic effect than was
bserved in the parental cell line.
An assessment of the ability of virus to replicate in
hese cells was further examined by performing virus
ield assays. For this study, cultures of the parental cell
ine as well as the hGBP-1 expressing clones were
nfected with VSV or EMCV and the virus yield was
etermined as described under Materials and Methods.
igure 3, which presents data generated in four experi-
ents performed on clones 67-6 and 67-7, reveals that
onstitutive expression of hGBP-1 results in an approxi-
ately 50% reduction in the amount of VSV and EMCV
roduced by these cells. To further study the antiviral
esponse observed in cells expressing hGBP-1, we in-
ected cells transiently transfected either with the pBact-
eo vector alone or with the pBactneo vector producing
GBP-1 mRNA with VSV or EMCV and assessed the virus
ield generated in these cells. A similar inhibition of both
SV and EMCV replication was observed (data not
hown). In experiments performed using the GBP sense-
roducing constructs, parallel cultures were prepared in
hich the number of cells present at the time of infection
as determined. No significant difference in the number
f cells in the different cell cultures was detected.
eneration of cells producing a reduced amount of
GBP-1 as a result of expression of antisense RNA
or hGBP-1
As the above studies indicate that the expression of
GBP-1 mediates an antiviral response in cells, we stud-
ed the role hGBP-1 plays in the IFN-mediated antiviral
esponse. For this study, hGBP-1 cDNA was incorporated
nto the pBactneo vector in an orientation that resulted in
FIG. 2. Examination of the cytopathic effect of VSV and EMCV in cells
onstitutively producing hGBP-1. HeLa cells and cells of clones 67-6
nd 67-7 were seeded in 24-well plates at a density of 105 cells/well
nd allowed to incubate at 37°C for 18 h at which time the wells were
nfected with either VSV or EMCV at an m.o.i. of 1. Eighteen hours later,
he culture medium present in the wells was removed, and the cells
ere washed twice with PBS and then stained with 20% ethanol
ontaining 10% crystal violet.
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10 ANDERSON ET AL.he production of antisense hGBP-1 RNA. This construct
as introduced into HeLa cells and cells isolated due to
heir resistance to G418 were assessed for their ability to
roduce hGBP-1 in response to IFN treatment. Two
lones, termed 67-2-AS and 67-4A-AS, were identified as
roducing hGBP-1 antisense RNA and less hGBP-1 pro-
ein in response to IFN-g treatment than was produced in
he parental cell line (Fig. 4).
FN-mediated antiviral response in cells inducing in
esponse to IFN treatment a reduced amount of
GBP-1 as a result of transfection with a construct
onstitutively expressing antisense RNA to hGBP-1
To examine the role hGBP-1 plays in the IFN-mediated
ntiviral state, cells producing a reduced amount of
GBP-1 as a result of constitutive expression of anti-
ense RNA to hGBP-1 were treated with no IFN or with
FIG. 3. Virus production in cells constitutively producing hGBP-1. He
density of 105 cells/well and allowed to incubate at 37°C for 18 h at wh
n 18-h incubation period, the virus yields were determined as describ
ields of the two clones constitutively expressing hGBP-1 compared to
FIG. 4. RT-PCR (A) and Western blot analysis (B) of cells stably transf
elative to the vector promoter. (A) 50 ng of DNase-treated total RNA
7-2-AS (2) and 67-4A-AS (3), stably transfected with a construct expr
GBP-1 RNA as described under Materials and Methods. RT-PCR s
hotographed under UV light. (B) Lysates prepared from the parental H
een treated for 18 h with 300 U/ml IFN-g were subjected to Western blot anFN-a or IFN-g for 18 h and then infected with either VSV
r EMCV at an m.o.i. of 1. The cells were harvested 18 h
ater and virus yields were determined as described
nder Materials and Methods. As can be seen in Fig. 5,
he reduced production of hGBP-1 in IFN-a-treated cells
ad little effect on the replication of VSV, while the virus-
nhibiting effect of IFN-a treatment on EMCV and the
irus-inhibiting effect of IFN-g treatment on both VSV and
MCV were greatly reduced in cells producing a reduced
mount of hGBP-1.
As the generation of double-stranded RNA in cells
roducing both the sense and the antisense forms of an
NA might interfere with the action of IFN-induced PKR
Schneider et al., 1985; Kitajewski et al., 1986; Katze et al.,
987), it was important to control for any effects mediated
y the generation of double-stranded RNA. To accom-
lish this, the IFN-mediated antiviral effect was exam-
s and cells of clones 67-6 and 67-7 were seeded in 24-well plates at
they were infected with either VSV or EMCV at an m.o.i. of 1. Following
er Materials and Methods. Results presented reflect the relative virus
rental cell line. The results are given as the means 6 SD (n 5 4).
ith a vector containing the hGBP-1 cDNA in the antisense orientation
d from the parental HeLa cell line (1) and two G418-resistant clones,
antisense hGBP-1 RNA, was analyzed for the presence of antisense
were run on a 0.8% ethidium bromide-containing agarose gel and
ll line or from two hGBP-1 antisense RNA-producing clones that hadLa cell
ich time
ed undected w
isolate
essing
amples
eLa ce
alysis as described under Materials and Methods.
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11ANTIVIRAL EFFECT OF THE IFN-INDUCED GBP-1ned in cells transfected with two constructs such that
hey produced both sense and antisense RNA to b-ga-
actosidase. These cells exhibited an IFN-mediated an-
iviral response comparable to that of the parental cell
ine (data not shown). This observation, taken together
ith the observation that PKR expression does not me-
iate an inhibition of VSV, suggests that the observations
ade in the hGBP-1 antisense RNA producing cells
esult from the reduced amount of GBP produced in
hese cells.
DISCUSSION
Since the dependence of the IFN-mediated antiviral
esponse on de novo RNA and protein synthesis was
bserved, investigators have studied the IFN-mediated
nduction of numerous proteins and RNAs. Through (1)
he generation of cells constitutively expressing IFN-
nduced gene products, (2) the generation of dominant
egative mutants blocking IFN-induced enzymatic path-
ays, and (3) the generation of mice incapable of pro-
ucing IFN-inducible gene products, scientists have
ained further insight into the role some of these gene
roducts play in IFN-mediated effects.
To examine the role that IFN-induced GBP-1 plays in
he IFN-mediated antiviral effect, we generated stably
nd transiently transfected cells constitutively producing
GBP-1 and cells inducing, in response to IFN treatment,
reduced amount of hGBP-1 as a result of having been
ransfected with a vector constitutively producing an an-
isense RNA to hGBP-1. Constitutive expression of
FIG. 5. Virus production in IFN-treated cells constitutively producing
nd 67-4A-AS were seeded in 24-well plates at a density of 5 3 104 c
ncubated for 18 h in the presence of 300 U/ml of IFN-a or IFN-g. These c
n 18-h incubation period, the cultures were harvested and the virus yiel
eflect the fold reduction in virus titers in the presence of IFN-a (A) or
D (n 5 3).GBP-1 in stably transfected cells results in an inhibition Tf the VSV- and EMCV-mediated cytopathic effects and
esults in a modest but reproducible reduction in the
mount of VSV and EMCV produced by these cells. Cells
ransiently transfected with the hGBP-1 producing con-
truct show a similar reduction in the amount of VSV and
MCV progeny produced. Taken together, these results
emonstrate that the expression of GBP-1 in the absence
f IFN treatment results in an inhibition of viral replica-
ion.
To examine the role hGBP-1 plays in the IFN-mediated
ntiviral effect, we generated cells constitutively produc-
ng antisense RNA to hGBP-1 that induced a reduced
mount of hGBP-1 in response to IFN treatment. Infection
f these IFN-treated cells revealed that they produce a
eaker IFN-a-mediated antiviral effect against EMCV
nd a weaker antiviral effect against both VSV and EMCV
n IFN-g-treated cells than is observed in the parental
ell line. These findings are consistent with those made
n cells constitutively producing hGBP-1. In light of the
referential induction of MxA in IFN-a-treated cells and
n light of the role MxA plays in the inhibition of VSV
Pavlovic et al., 1990), and the minimal induction of GBP-1
bserved in IFN-a-treated cells (Rubin et al., 1988b), it is
erhaps not surprising that the production of antisense
NA to hGBP-1 had no effect on the ability of IFN-a to
nhibit VSV. Conversely, in IFN-g-treated cells in which
here is minimal IFN-mediated MxA induction but a
trong induction of GBP-1 (Rubin et al., 1988b), the inhi-
ition of GBP-1 production was sufficient to partially
brogate the IFN-induced antiviral activity against VSV.
se RNA to the hGBP-1 mRNA. HeLa cells and cells of clones 67-2-AS
d allowed to incubate at 37°C for 24 h at which time the cells were
were then infected with either VSV or EMCV at an m.o.i. of 1. Following
rmined as described under Materials and Methods. Results presented
(B) in the respective cell lines. The results are given as the means 6antisen
ells an
ultures
ds dete
IFN-ghe reduced antiviral effect observed in the IFN-a- and
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12 ANDERSON ET AL.FN-g-treated cells infected with EMCV, which is not
nhibited by MxA expression (Pavlovic et al., 1990), sug-
ests that MxA and GBP-1 may serve as nonredundant
ffectors of IFN-mediated antiviral activities.
While early experiments suggested that IFN-a is a
ore potent inhibitor of VSV and EMCV than is IFN-g
Rubin and Gupta, 1980), subsequent studies have re-
ealed that the degree of responsiveness to the different
FNs is dependent on the cell type being studied and that
ven clonal isolates of a single cell line can differ in their
ntiviral responsiveness to either IFN-a or IFN-g (Kumar
t al., 1987). Examination of the data presented in Fig. 5
eveals that in the HeLa cell line we employed in this
tudy, IFN-g mediates a more potent antiviral effect
gainst VSV and EMCV than does IFN-a.
As the antisense RNA produced in the cells we stud-
ed would likely interact with other members of the IFN-
nduced GBP family, it is possible that the effect ob-
erved in cells producing the antisense RNA for GBP-1
ight be due to an inhibition of the synthesis of GBP-1 as
ell as other members of this gene family.
Since the production of double-stranded RNA has
een observed to interfere with the action of the IFN-
nduced PKR (Schneider et al., 1985; Kitajewski et al.,
986; Katze et al., 1987) and might through other un-
nown mechanisms interfere with the antiviral action of
he IFNs, it was necessary to assess whether the pro-
uction of double-stranded RNA in the antisense RNA-
roducing cells might explain the reduced IFN-mediated
ntiviral response observed in these cells. For these
tudies cells generated that produced both sense and
ntisense RNA for b-galactosidase were treated with IFN
nd the antiviral response of these cells was assessed.
he simultaneous production of both the sense and the
ntisense RNAs had no effect on the IFN-mediated an-
iviral effect.
With these findings we establish that constitutive ex-
ression of hGBP-1 results in an inhibition of the repli-
ation of VSV and EMCV and that the reduced ability of
FN-treated cells to produce GBP-1 results in an elevated
roduction of viral progeny. These findings provide the
irst evidence that GBP-1 plays a critical role in the
nhibition of VSV and EMCV replication. Interestingly
hile both MxA and GBP-1 exhibit GTPase activity, their
irus specificity differs, as GBP-1 is capable of inhibiting
he replication of both VSV and EMCV while MxA is
ncapable of inhibiting the replication of EMCV (Pavlovic
t al., 1990). The observed ability of GBP-1 to mediate an
ntiviral effect may in part explain the results of Pine
1992) and Kimura et al. (1994), who report that modula-
ion of expression of IRF-1, which results in an alteration
n the levels of various gene products including GBP-1,
lso results in a corresponding effect on the replication
f VSV and EMCV. aMATERIALS AND METHODS
aterials
FS4 cells and the pBactneo vector were kindly pro-
ided by J. Vilcek. HeLa cells were obtained from the
merican Type Culture Collection. Recombinant human
FN-a and IFN-g were purchased from Collaborative Re-
earch and Promega Corp., respectively. Recombinant
ouse IFN-a and IFN-g were purchased from PBL Bio-
edical Laboratories. Radioisotopes were purchased
rom NEN Life Science Products.
NA preparation
Total RNA was prepared using the RNAqueous kit
urchased from Ambion.
DNA library construction
A lgt10 cDNA library was constructed from RNA iso-
ated from IFN-g-treated FS4 cells using the Riboclone
DNA Synthesis System, EcoRI Adaptor Ligation System,
nd Packagene Lambda DNA Packaging System accord-
ng to the manufacturer’s directions (Promega Corp.).
ransfection of HeLa cells
Dishes (60 mm) containing approximately 5 3 105 cells
ere washed with serum-free medium and then incu-
ated for 24 h in serum-free medium to which a mixture
f 5 mg of DNA and 10 ml Transfectam (Promega Corp.)
as added. For the generation of stable transfectants,
he cells were trypsinized the next day and transferred to
ulture dishes with medium containing G418. G418-resis-
ant colonies were harvested and immediately sub-
loned by serial dilution. For the generation of transiently
ransfected cells, cells were trypsinized the day after
ransfection, placed in new wells, and allowed to recover
or 24 h in culture medium before virus experiments were
erformed.
mmunoprecipitations
Immunoprecipitations on cell extracts containing
qual amounts of radioactivity were performed as de-
cribed (Rubin et al., 1988a) using a monoclonal antibody
enerated against hGBP-1.
estern blot analysis
Cell lysates were prepared, fractionated, and charac-
erized by Western blot analysis using a monoclonal
ntibody to hGBP-1 as described (Margolis-Nunno et al.,
990).
nfection with virus and determination of virus yield
Cells seeded in 24-well plates (5 3 104 cells/well)
ere challenged with VSV or EMCV at a m.o.i. of 1. Virus
dsorption was for 1 h at 37°C, and then the cells were
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13ANTIVIRAL EFFECT OF THE IFN-INDUCED GBP-1ashed and incubated for 18 h at 37°C. The cultures
ere then frozen and thawed three times and the virus
ields were determined as described (Rubin and Gupta,
980). Alternatively, cells were stained with 10% crystal
iolet in a 20% ethanol solution immediately following an
8-h incubation period.
everse transcriptase-polymerase chain reaction
RT-PCR)
RT-PCR was performed using the GeneAmp RNA PCR
it (Perkin–Elmer) according to the manufacturer’s direc-
ions. All RNA samples upon which RT-PCR was per-
ormed were digested extensively with DNase; experi-
ents performed demonstrated that no PCR products
ere generated from these RNA preparations in the
bsence of the reverse transcriptase. For the detection of
he antisense RNA for GBP-1, we generated a 1170-bp
T-PCR product from 50 ng of total RNA using primer
9-TGACCTACGTCAATGCCATC-39 for first-strand synthe-
is and added primer 59-GTCTACTGCTGGTCATCTGG-39
or second-strand synthesis and subsequent amplifica-
ion.
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